Litcius/Paper detail

Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer

Yanting Lin, Yiming Liu, Zhenhua Gao, Dongquan Jing, Ran Bi, Xinmeng Cui, Qiuhua Cao, Qixiang Zhao, Rui Gao, Yali Su, Siliang Liu, Mingrui Zhao, Yong Yang, Anqi Chen, Beiying Dai, Xinghua Gao, Beiying Dai, Xinghua Gao

2023European Journal of Pharmacology39 citationsDOI

Topics & Concepts

MedicineColorectal cancerCD8Immune systemPharmacologyCancer researchIrinotecanCancerImmunologyInternal medicineCancer, Stress, Anesthesia, and Immune ResponseCancer Immunotherapy and BiomarkersChemokine receptors and signaling
Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer | Litcius